SU Lin-Jie, REN Yu-Chuan, CHEN Zhuo, MA Hui-Fen, ZHENG Fan, LI Fang, ZHANG Yuan-Yuan, GONG Shuai-Shuai, KOU Jun-Ping. Ginsenoside Rb1 improves brain, lung, and intestinal barrier damage in middle cerebral artery occlusion/reperfusion (MCAO/R) mice via the PPARγ signaling pathway [J].Chin J Nat Med, 2022, 20(8): 561-571. DOI: 10.1016/S1875-5364(22)60204-8
Citation: SU Lin-Jie, REN Yu-Chuan, CHEN Zhuo, MA Hui-Fen, ZHENG Fan, LI Fang, ZHANG Yuan-Yuan, GONG Shuai-Shuai, KOU Jun-Ping. Ginsenoside Rb1 improves brain, lung, and intestinal barrier damage in middle cerebral artery occlusion/reperfusion (MCAO/R) mice via the PPARγ signaling pathway [J].Chin J Nat Med, 2022, 20(8): 561-571. DOI: 10.1016/S1875-5364(22)60204-8
shu

Ginsenoside Rb1 improves brain, lung, and intestinal barrier damage in middle cerebral artery occlusion/reperfusion (MCAO/R) mice via the PPARγ signaling pathway

    Graphical Abstract
    • Abstract
  • Ischemic stroke causes brain inflammation and multi-organ injury, which is closely associated with the peroxisome proliferator-activated receptor-gamma (PPARγ) signaling pathway. Recent studies have indicated that ginsenoside Rb1 (GRb1) can protect the integrity of the blood-brain barrier after stroke. In the current study, a mouse model of middle cerebral artery occlusion/reperfusion (MCAO/R) was established to determine whether GRb1 can ameliorate brain/lung/intestinal barrier damage via the PPARγ signaling pathway. Staining (2,3,5-triphenyltetrazolium chloride, hematoxylin, and eosin) and Doppler ultrasonography were employed to detect pathological changes. Endothelial breakdown was investigated with the leakage of Evans Blue dye and the expression of TJs (tight junctions) and AJs (adherent junctions). Western blot and immunofluorescence were used to determine the levels of cell junction proteins, PPARγ and NF-κB. Results showed that GRb1 significantly mitigated multi-organ injury and increased the expression of cerebral microvascular, pulmonary vascular, and intestinal epithelial connexins. In brain, lung, and intestinal tissues, GRb1 activated PPARγ, decreased the levels of phospho-NF-κB p65, and inhibited the production of proinflammatory cytokines, thereby maintaining barrier permeability. However, co-treatment with GRb1 and the PPARγ antagonist GW9662 reversed the barrier-protective effect of GRb1. These findings indicated that GRb1 can improve stroke-induced brain/lung/intestinal barrier damage via the PPARγ pathway.
    • FullText(HTML)
  • loading
    • References (61)
    • Related Articles

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return